Cutaneous and systemic connections in lupus.

Area of Science:

• Immunology
• Dermatology
• Rheumatology

Background:

• Systemic lupus erythematosus (SLE) is a complex autoimmune disease affecting multiple organs.
• Cutaneous lupus erythematosus (CLE) is a common manifestation in SLE patients, yet its specific pathogenesis and link to SLE remain unclear.

Purpose of the Study:

• To review recent advances in understanding the pathogenesis of SLE and CLE.
• To compare the underlying mechanisms driving both systemic and cutaneous lupus erythematosus.

Main Methods:

• Review of recent immunological studies and clinical trial data.
• Comparative analysis of immune cell involvement in SLE and CLE pathogenesis.

Main Results:

• Transitional B cells and BAFF signaling are implicated in both SLE and CLE.
• Regulatory T cells (Tregs) and T-cell-targeted therapies show promise.
• Neutrophils may drive cutaneous disease, while their role in SLE autoantigenicity is debated.
• Plasmacytoid dendritic cells (pDCs) are a therapeutic target, with anti-BDCA antibodies showing efficacy in CLE.

Conclusions:

• Recent findings illuminate shared immune pathways in SLE and CLE.
• Further research is needed to fully elucidate the mechanistic link between systemic and cutaneous lupus.
• Targeting specific immune cell populations offers potential therapeutic strategies for both conditions.